2015
DOI: 10.1185/03007995.2015.1128405
|View full text |Cite
|
Sign up to set email alerts
|

Clinician reported ease of use for a novel fibrin sealant patch for hemostasis: results from four randomized controlled trials

Abstract: Physicians consistently reported high EUQ scores for the fibrin sealant patch across surgical bleeding populations. An important limitation of this study was that the composition of SoC varied across studies and EUQ data were only available for the SoC in two of four trials. Future studies should evaluate ease of use for other hemostats and across other surgical subspecialties, as data are currently limited.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 35 publications
0
7
0
Order By: Relevance
“…First, THA, no matter of the product used, is highly appreciated by liver surgeons – as recently highlighted in a Dutch survey – in order to reduce intraoperative blood loss, TTH and potential bile leakage . A fibrin sealant patch is often preferred since it seems the friendliest tool to use . Second, the best results – all outcomes confounded – seem to be obtained with the carrier‐bound fibrin sealant, homemade or ready‐to‐use, that combines the effects of a matrix with active agents to trigger and accelerate coagulation.…”
Section: Discussionmentioning
confidence: 99%
“…First, THA, no matter of the product used, is highly appreciated by liver surgeons – as recently highlighted in a Dutch survey – in order to reduce intraoperative blood loss, TTH and potential bile leakage . A fibrin sealant patch is often preferred since it seems the friendliest tool to use . Second, the best results – all outcomes confounded – seem to be obtained with the carrier‐bound fibrin sealant, homemade or ready‐to‐use, that combines the effects of a matrix with active agents to trigger and accelerate coagulation.…”
Section: Discussionmentioning
confidence: 99%
“…Fibrin sealants formed by mixing fibrinogen and thrombin are widely used to stop bleeding (Corral et al 2016). Importantly, various commercially available fibrin sealants have diverse mechanical properties (Hickerson et al 2011) and glues with distinct structure and stiffness had different hemostatic efficacy (Fortelny et al 2011).…”
Section: 5 Fibrin Mechanical Properties and Their Structural Originsmentioning
confidence: 99%
“…A viscoelastic fibrin clot is necessary to prevent blood loss and promote wound healing. In surgery, fibrin sealants are formed from concentrated (up to 60 mg/mL) Fg followed by application to a bleeding wound to achieve hemostasis . Fg might polymerize without proteolytic action, but the (patho)­physiological implications of this phenomenon are unclear.…”
Section: Introductionmentioning
confidence: 99%
“…In surgery, fibrin sealants are formed from concentrated (up to 60 mg/mL) Fg followed by application to a bleeding wound to achieve hemostasis. 2 Fg might polymerize without proteolytic action, 3 but the (patho)physiological implications of this phenomenon are unclear. Due to various functions in blood clotting, Fg molecules are also involved in many intermolecular interactions and, therefore, the physical molecular characteristics of Fg are of paramount importance for biology and medicine.…”
Section: ■ Introductionmentioning
confidence: 99%